OEA and LipiSperse Metabolic Study

Exclusion Criteria

• •Have a serious illness e.g. neurological disorders such as MS, kidney disease, liver disease or heart conditions
• •History of any glucose or insulin regulation problem, including diabetes.
• •Have an unstable illness e.g. thyroid gland dysfunction, uncontrolled mood disorders (e.g., depression, anxiety, bipolar).
• •Diagnosed with any known metabolic or endocrine dysfunctions e.g., diabetes, NAFLD, hyperinsulinemia, hypoglycaemia.
• •Use of any medication or supplements that may affect any metabolic pathway associated with satiety (e.g., GLP-1, GIP, glucagon), glucose or insulin.
• •Current malignancy (excluding Basal Cell Carcinoma) or chemotherapy or radiotherapy treatment for malignancy within the previous 2 years
• •Significant change in diet in the past 1-month (e.g., removal of a food group or calorie restriction)
• •Active smokers, nicotine use or drug (prescription or illegal substances) abuse
• •Chronic past and/or current alcohol use (\>21 alcoholic drinks week)
• •Pregnant or lactating women
• •Allergic to any of the ingredients in active or placebo formula
• •Participants who are or who have participated in any other clinical trial during the past 1 month (excludes RDC clinical trials which are to be assessed on a case-by-case basis).
• •Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion
• •Regular use within the past 4 weeks of supplements containing OEA and/or LipiSperse